Project:
CeO2 Nanoparticles-assisted stem cell therapy
Registration number:TH70020001
Realization period:01.01. 2020 – 31.12. 2022
Leader at TUL:RNDr. Alena Ševců, Ph.D.
The main objective of CELLUX is to develop a novel pharmaceutical-based CeO2 eye drops to treat AMD (Age-related Macular Degeneration) that in combination with stem cell-based therapeutic strategies, will not only stop degeneration but restore vision.
This project is funded with state support from the Technology Agency of the Czech Republic
.jpeg)
.png)
.jpeg)
.jpeg)
.png)
.jpeg)
.png)
.png)